GeneSystem Co

GeneSystem Co R&D per Employee

The R&D Spending per Employee of GeneSystem Co (363250.KQ) as of Oct 29, 2026 is 35.85 M KRW. In the previous year, R&D Spending per Employee was 44.59 M KRW — a change of -19.59% (lower).

R&D per Employee

35.85 MKRW

YoY

-19.59%

Last updated:

R&D Spending per Employee of GeneSystem Co is 2025 35.85 M KRW. R&D Spending per Employee of GeneSystem Co was 2024 44.59 M KRW. It decreases by -19.59% lower compared to the previous year.

The GeneSystem Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2020
21.75 M KRW
Jan 1, 2021
37.89 M KRW
Jan 1, 2022
44.71 M KRW
Jan 1, 2023
45.67 M KRW
Jan 1, 2024
44.59 M KRW
Jan 1, 2025
35.85 M KRW
The GeneSystem Co R&D per Employee history
YEARR&D per EmployeeYoY
35.85 MKRW-19.59%
44.59 MKRW-2.37%
45.67 MKRW+2.14%
44.71 MKRW+18.00%
37.89 MKRW+74.21%
21.75 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

GeneSystem Co Stock analysis

What does GeneSystem Co do? GeneSystem Co., Ltd generates revenue through the development, manufacturing, and sale of PCR-based molecular diagnostic products. The company offers molecular diagnosis systems, biochips, test kits, and reaction reagents, targeting healthcare providers and laboratories seeking advanced in vitro diagnostic solutions. Its core business focuses on molecular diagnosis technology, complementing immunodiagnosis technology to deliver comprehensive diagnostic tools. The firm serves medical institutions requiring precise and efficient diagnostic equipment for disease detection and monitoring. The company's product portfolio includes platform-based molecular diagnostic systems, biochips, and test kits designed for laboratory use. These products are sold directly to healthcare facilities and diagnostic laboratories, supporting applications in infectious disease testing and genetic analysis. By leveraging its expertise in molecular diagnosis, GeneSystem Co., Ltd provides essential tools for medical professionals to enhance diagnostic accuracy and patient care. GeneSystem Co., Ltd's revenue streams are derived from the sale of diagnostic systems, biochips, and consumables such as test kits and reaction reagents. The firm's target market comprises healthcare institutions and laboratories that require reliable in vitro diagnostic technology. The company's focus on molecular diagnosis technology positions it as a key supplier in the diagnostic equipment sector, meeting the growing demand for advanced diagnostic solutions in healthcare. GeneSystem Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GeneSystem Co stock

R&D Spending per Employee of GeneSystem Co is 35.85 M KRW in 2025.

R&D Spending per Employee of GeneSystem Co changed from 44.59 M KRW to 35.85 M KRW, representing a -19.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee GeneSystem Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's GeneSystem Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — GeneSystem Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — GeneSystem Co